These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11707593)

  • 1. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.
    Kaplan D; Smith D; Meyerson H; Pecora N; Lewandowska K
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13850-3. PubMed ID: 11707593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody specificity and immunoglobulin VH gene utilization of human monoclonal CD5+ B cell lines.
    Schutte ME; Ebeling SB; Akkermans KE; Gmelig-Meyling FH; Logtenberg T
    Eur J Immunol; 1991 May; 21(5):1115-21. PubMed ID: 1709863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.
    Casali P; Notkins AL
    Annu Rev Immunol; 1989; 7():513-35. PubMed ID: 2469441
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
    Wang EC; Lehner PJ; Graham S; Borysiewicz LK
    Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of interleukin 2 receptors in in vivo Epstein-Barr virus transformed B lymphocytes].
    Becker H; Helmke K; Federlin K
    Immun Infekt; 1988 Feb; 16(1):21-2. PubMed ID: 2834287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.
    McLaren JE; Zuo J; Grimstead J; Poghosyan Z; Bell AI; Rowe M; Brennan P
    J Gen Virol; 2009 Sep; 90(Pt 9):2239-50. PubMed ID: 19439556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of the extracellular domains of rabbit recombinant CD5: development and characterization of polyclonal and monoclonal antibodies.
    Pospisil R; Obiakor H; Newman BA; Alexander C; Mage RG
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):257-67. PubMed ID: 15621311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to Epstein-Barr virus in atomic bomb survivors: study of precursor frequency of cytotoxic lymphocytes and titer levels of anti-Epstein-Barr virus-related antibodies.
    Kusunoki Y; Kyoizumi S; Fukuda Y; Huang H; Saito M; Ozaki K; Hirai Y; Akiyama M
    Radiat Res; 1994 Apr; 138(1):127-32. PubMed ID: 8146292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.